Overview

Dexmedetomidine and 5-year Outcome in Elderly Patients After Surgery

Status:
Completed
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
Delirium is a frequent postoperative complication. Its occurrence is associated with worse long-term outcomes. In a previous randomized controlled trial, prophylactic low-dose dexmedetomidine infusion during the early postoperative period decreased the incidence of delirium in elderly patients after surgery. The purpose of this 5-year follow-up study is to evaluate whether prophylactic low-dose dexmedetomidine infusion can improve the 5-year outcomes in elderly patients recruited in the previous randomized controlled trial.
Phase:
N/A
Details
Lead Sponsor:
Peking University First Hospital
Collaborator:
Peking University Third Hospital
Treatments:
Dexmedetomidine